Curaleaf is a leading vertically integrated medical and wellness cannabis operator in the United States.
Curaleaf is committed to being the industry’s leading resource in education and advancement through research and advocacy.
Headquartered in Wakefield, Massachusetts, Curaleaf has a presence in 12 states, owns and operates 42 dispensaries, 12 cultivation sites and 10 processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York.
Curaleaf leverages its extensive research and development capabilities to distribute cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care.
Delivering Premium Quality Products
Through our team of physicians, pharmacists, medical experts and industry visionaries, we have created a premier, branded, cannabis-based therapeutic offering under the Curaleaf brand.
Curaleaf’s highly qualified, in-house research and development team designs and operates cultivation sites that meet good agricultural practices (GAP) while producing optimal yields of high-quality and consistent medical cannabis.
Curaleaf leverages its extensive R+D capabilities to train its staff in superior extraction techniques to formulate premium branded products, including oils for vaporizing, cartridges, concentrates, tinctures, mints, capsules, edibles, and flower pods. Strain-specific terpene profiles have been rolled out in every state.
Dedication to Patients
Dedication to Patients – Curaleaf’s dedicated dispensary team have served more than 87,000 registered patients since the inception of operations in each medical state. Its dispensary associates are known for educating and guiding patients through the available product forms, dosing and strains to help each patient make the best choice for their condition.